ICON plc
(NASDAQ : ICLR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 10.38%48.510.0%$558.21m
VRXValeant Pharmaceuticals International, Inc. -1.02%27.2714.1%$160.46m
CTLTCatalent, Inc. -1.56%136.012.0%$156.22m
PRGOPerrigo Co. Plc -1.11%43.796.9%$137.53m
ICLRICON plc -0.94%268.192.8%$117.70m
INDPIndaptus Therapeutics, Inc. -12.95%10.080.0%$111.65m
HZNPHorizon Therapeutics Plc 1.63%109.715.5%$103.63m
JAZZJazz Pharmaceuticals Plc 1.12%133.222.1%$97.67m
ARGXargenx SE 2.50%331.670.0%$60.05m
ENDPEndo International Plc 4.04%2.838.5%$55.42m
AXSMAxsome Therapeutics, Inc. 4.17%29.721.8%$52.84m
UTHRUnited Therapeutics Corp. -2.47%200.0814.0%$50.73m
BHCBausch Health Cos., Inc. -1.02%27.270.0%$49.51m
SNOASonoma Pharmaceuticals, Inc. 0.75%5.353.4%$33.25m
SAGESAGE Therapeutics, Inc. 2.43%46.407.6%$22.43m

Company Profile

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.